Growth hormone inhibits the interleukin-6 induced junB protooncogene and fibrinogen expression in HepG2 human hepatoma cells

被引:0
|
作者
Igaz, P [1 ]
Dérfalvi, B [1 ]
Tóth, S [1 ]
Falus, A [1 ]
机构
[1] Semmelweis Univ Med, Sch Med, Dept Genet Cell & Immunobiol, H-1445 Budapest, Hungary
来源
ACTA BIOLOGICA HUNGARICA | 1998年 / 49卷 / 01期
关键词
growth hormone; interleukin-6; junB mRNA; fibrinogen;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Growth hormone (GH) and interleukin-6 (IL-6) play important regulatory roles in multiple endocrinological and immunological functions. In this study we examined whether GH can modulate the actions of IL-6. In HepG2 human hepatoma cells we studied the effects of different GH concentrations on the expression of the junB mRNA as an early and on the biosynthesis of fibrinogen protein as a late model of IL-6-related hepatic response. Both GH and IL-6 alone induced the expression of junB and fibrinogen but GH significantly inhibited the actions of higher (10 and 20 ng/ml) IL-6 concentrations in a dose dependent manner. These findings further underline the importance of interplay between the effectiveness of IL-6 and GH in various physiological processes.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 50 条
  • [41] MICROENCAPSULATED HUMAN HEPATOMA (HEPG2) CELLS - IN-VITRO GROWTH AND PROTEIN RELEASE
    ULUDAG, H
    SEFTON, MV
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1993, 27 (10): : 1213 - 1224
  • [42] Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-10 and tumor necrosis factor-α, but is upregulated by interleukin-6
    Kumon, Y
    Suehiro, T
    Ikeda, Y
    Hashimoto, K
    LIFE SCIENCES, 2003, 73 (22) : 2807 - 2815
  • [43] Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells
    Chen, Chuan
    Han, Zhu
    Yang, Minjie
    Jiang, Zhongke
    Ou, Xiuyuan
    MEDICINE, 2020, 99 (17) : E19848
  • [44] Anticancer effects of pyocyanin on HepG2 human hepatoma cells
    Zhao, J.
    Wu, Y.
    Alfred, A. T.
    Wei, P.
    Yang, S.
    LETTERS IN APPLIED MICROBIOLOGY, 2014, 58 (06) : 541 - 548
  • [45] Metabolism of petrogenic PAHs in human hepatoma (HepG2) cells
    Huang, Meng
    Blair, Ian A.
    Penning, Trevor M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [46] The transcriptional signature of dioxin in human hepatoma HepG2 cells
    Puga, A
    Maier, A
    Medvedovic, M
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) : 1129 - 1142
  • [47] Characterization and modulation of LP(a) in human hepatoma HEPG2 cells
    Vu, H
    Cianflone, K
    Zhang, ZJ
    Kalant, D
    Sniderman, AD
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1997, 1349 (02): : 97 - 108
  • [48] Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells
    Valdameri, Glaucio
    Trombetta-Lima, Marina
    Worfel, Paulo R.
    Pires, Amanda R. A.
    Martinez, Glaucia R.
    Noleto, Guilhermina R.
    Cadena, Silvia M. S. C.
    Sogayar, Mari C.
    Winnischofer, Sheila M. B.
    Rocha, Maria E. M.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 193 (02) : 180 - 189
  • [49] Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells
    Kuo, HC
    Lee, HJ
    Hu, CC
    Shun, HI
    Tseng, TH
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 210 (1-2) : 55 - 62
  • [50] Streptozotocin-induced cytotoxicity and mitochondrial dysfunction in human hepatoma HepG2 cells
    Raza, Haider
    John, Annie
    CANCER RESEARCH, 2010, 70